TC BioPharm (NASDAQ: TCBP) , a clinical-stage biotechnology company, announced a change in the ratio of its American Depositary Shares (“ADSs”) to or ...
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...
CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...
A mid-sized German bakery has installed six industrial robots to help it cope with expanding demand and to improve the efficiency of its operations. The family-run Malzers bakery supplies the Ruhr ...
Plc (NASDAQ:TCBP – Free Report) are set to reverse split on Monday, February 10th. The 1-20 reverse split was announced on Wednesday, February 5th. The number of shares owned by shareholders will be ...
A Japan Airlines plane that was taxiing on the tarmac of Seattle-Tacoma International Airport apparently clipped the tail of a parked Delta aircraft on Wednesday morning, airport ...
As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally. However, the Company can give no assurance that the ADS trading price after the ADS Ratio Change will ...
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...